Article: BIOPRO Baden-Wurttemberg GmbH Helps Secure EUR 8.6 Million Investment in BioRegionUlm; Successful Biotech-Pharma Cooperation in Baden-Wurttemberg (Germany).

STUTTGART & ULM & LAUPHEIM, Germany -- A regional consortium is investing EUR 8.6 million in the biotech start-up CELLCA GmbH in Laupheim. CELLCA GmbH and Rentschler Biotech GmbH, Laupheim, have agreed to cooperate following the financing. The process was significantly supported by IHK Ulm, BioRegionUlm and the SYNPRO team of BIOPRO Baden-Wurttemberg GmbH. E[acute accent]The CELLCA GmbH start-up was founded in order to develop and use new technology for the optimized biotechnological production of pharmaceutical substances. CELLCA GmbH is working on a new production process based on stable production stocks. As a partner, Rentschler can use this new technology for its own ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!